Genentech Reports Positive Topline Results From Vabysmo Trial In Retinal Vein Occlusion
SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of Swiss drug major Roche Group (RHHBY), announced Thursday positive topline results from Phase III trials that showed Vabysmo improved vision